Stryker Corporation (SYK)

336,85 +1,94 (+0,58%) Börsenschluss: 04:00PM EDT

Stryker Corporation

1941 Stryker Way
Portage, MI 49002
United States
269 385 2600
https://www.stryker.com

Sektor(en): Healthcare
Branche: Medical Devices
Vollzeitmitarbeiter: 52.000

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Mr. Kevin A. Lobo	Chairman, CEO & President	5,7M	33,71M	1965
Mr. Glenn S. Boehnlein	VP & CFO	2,27M	5,44M	1962
Mr. Viju S. Menon	Group President of Global Quality & Operations	1,68M	N/A	1968
Mr. J. Andrew Pierce	Group President of MedSurg & Neurotechnology	2,03M	2,69M	1974
Mr. Spencer S. Stiles	Group President of Orthopaedics & Spine	2,02M	2,33M	1977
Mr. William E. Berry Jr.	VP & Chief Accounting Officer	N/A	N/A	1966
Mr. Robert C. Cohen	CTO and VP of Global R&D - Joint Replacement	N/A	N/A	N/A
Mr. Alan Douville	VP, Chief Information Officer & Chief Information Security Officer	N/A	N/A	N/A
Mr. Jason Beach	Vice President of Finance & Investor Relations	N/A	N/A	N/A
Mr. Robert S. Fletcher	VP & Chief Legal Officer	895,89k	N/A	1971

Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.

Beschreibung

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.

Corporate Governance

Stryker Corporations ISS Governance QualityScore, Stand 1. April 2024, lautet 6. Die grundlegenden Scores sind Audit: 7, Vorstand: 5, Shareholderrechte: 6, Kompensation: 5.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.